Neogen Chemicals Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ghbdt98dg5rxnccnocjxshw3.pdf

Key Takeaways


Battery Chemicals: The Big Guidance Reset

Harin Kanani: "Based on today's situation, as I explained earlier, since our electrolyte demand has been lower, although we are ready and we took longer time for getting approval, we are expecting it longer. So this year, we would not be able to achieve INR 300 crore."

The FEOC Opportunity & Competitive Position

Harin Kanani: "One of the biggest help China did to market our product is the restrictions they announced from 8th November. Because that really shook up the customers because at any point of time, if China comes and says, hey, I will not supply this and I will not supply that."

Morita JV & Technology Moat

Harin Kanani: "only we offer the combination of low cost from India with reliability from international technology for electrolyte salt, specifically LiPF6, which is seen very positively by the customers."

Base Business: Steady Despite the Fire


Profitability & Fire Aftermath


Balance Sheet & Capex


Guidance & Commitments

CommitmentSpecificsTimeline
Battery chemicals FY26 revenue₹30–40 crore (revised from ₹300 crore)FY26
Battery chemicals FY27 revenueAt least ₹400–500 croreFY27
Battery chemicals FY28 revenueMore than ₹1,000 croreFY28
Battery chemicals full utilization revenue₹2,400–2,900 croreFY29
Base business FY26 revenue₹850 crore (standalone)FY26
Base business FY27 revenue₹950–1,000 crore (full utilization)FY27
Electrolyte salt final approvalsCustomer-requested improvements complete by Jan/Feb 2026; final approval visit possible Jan/Feb 2026Q4 FY26
Greenfield facility commercial productionElectrolyte in H1 FY27; electrolyte salt in H2 FY27FY27
Peak debt~₹1,800 croreAround FY28
Standalone EBITDA margin at full utilization18% ± 1–1.5%FY27
Insurance stock-related claimMajority receivedQ3 FY26
Insurance loss-of-profit claimReceivedQ2/Q3 FY27
Rebuilt Dahej plant availabilityOperationalFY27

Key Metrics

MetricQ2 FY26
Consolidated revenue₹209 cr, up 8% YoY
Organic revenue₹184 cr, up 12% YoY
Inorganic revenue (Neogen Ionics)₹5.42 cr
Gross profit growth16% YoY, with 350 bps margin expansion
EBITDA₹30 cr
PAT₹3 cr
Standalone debt₹722 cr; net debt ₹595 cr
Consolidated total debt₹1,078 cr; net debt ₹900 cr
Liquid investments₹167 cr as on quarter end
Trailing 12-month DSCR2.1 times
NCDs raised₹200 cr via private placement
Battery chemicals FY26 revenue guidance₹30 cr to ₹40 cr, revised from earlier ₹300 cr
Battery chemicals FY27 revenue target₹400 cr to ₹500 cr
Battery chemicals full utilization revenue target₹2,400 cr to ₹2,900 cr by FY29
Base business FY26 revenue plan₹850 cr, on track
Base business FY27 full utilization target₹950 cr to ₹1,000 cr
Peak gross debt expected₹1,800 cr, around FY28
Capex completed so far₹620 cr; another ₹500 cr expected by year-end; total ₹1,500 cr across Dahej and Pakhajan
Insurance proceeds received₹80 cr; ~₹300 cr remaining to be received over next one year
Electrolyte PPAP approvalAchieved from a leading Indian gigascale customer
Salt provisional approvalReceived from key international customer; final approval expected Q4 FY26 or Q1 FY27
Neogen Ionics FY27 revenue split~50% electrolyte, ~50% salt
Standalone margin guidance FY2718% plus or minus 1% to 1.5% at full utilization
Consolidated gross block by FY27 end~₹2,000 cr
ROCE at full utilization20% on a stable basis; may be lower in intermediate phase